Fellow
Boston Children's Hospital
Boston, Massachusetts
I am a surgeon-scientist committed to improving the outcome for otolaryngology patients. The main focus of my research is on translational and clinical variables associated with outcome and quality of life in rhinology, skull base, head and neck cancer, and otology. My current appointment is as a Post-doctoral Research Fellow at The Translational Hearing Genomics Lab at the Boston Children's Hospital. Our goal is to improve the lives of children with hearing loss. The current lab focuses include the use of exome, genome, and RNA sequencing to 1) improve our understanding of the physiology of hearing, 2) correlate genetics with speech and hearing outcomes in particular among cochlear implant users, 3) advance genetic testing for deafness using new sequencing technologies, and 4) establish diagnostic accuracy before proceeding with gene therapy. Human studies, mouse models, and in vitro experiments will all be used to achieve this goal.
I was previously based at the Department of Otolaryngology - HNS at LSU Health Shreveport, under the guidance of Dr. Cherie-Ann Nathan. I undertook various Head and Neck Cancer-related translational research projects and presented at national meetings. These projects include the determination of cell-free circulating tumor DNA mutational profiles in oropharyngeal squamous cell carcinoma (OPSCC), radiosensitization of HPV (+) PIK3CA mutant Head and Neck Squamous Cell Carcinoma (HNSCC), adjuvant therapy with mTOR inhibitors in P53-mutant HNSCC, targeting FGFR-2b in prevention and treatment of cSCC, and the role of CXCL17 in UVB-induced cutaneous SCC. Due to my clinical background, I am also involved in clinical research projects, specifically regarding the quality of life of tracheostomy decannulation in laryngeal cancer patients and metformin and NSAID effect in the development of head and neck cancer. I am interested in translational research, especially in adjuvant therapy for thyroid carcinoma.
Disclosure information not submitted.
Wednesday, April 27, 2022
11:15 AM – 12:00 PM CT